PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
22-Aug-2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development Vandria SA
22-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
22-Aug-2024 London BioScience Innovation Centre welcomes Baseimmune Ltd to its new fully fitted grow-on lab space within the Apex Building London BioScience Innovation Centre
22-Aug-2024 RedHill Announces Positive Obesity and Diabetes Results with Opaganib RedHill Biopharma
22-Aug-2024 Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor Adcendo ApS and Multitude Therapeutics Inc
20-Aug-2024 Pen Needles Market Size to Reach USD 3.5 Billion by 2029, Says The Maximize Market Research. Maximize Market Research Pvt. Ltd.
16-Aug-2024 CV6 Therapeutics Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168 CV6 Therapeutics
15-Aug-2024 Phastar named in 2024 Environment 100 List Phastar
14-Aug-2024 OrganaBio Manufactures First GMP Cryopreserved Leukopaks for Two New Biopharma Partners’ Allogeneic Cell Therapies OrganaBio
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
14-Aug-2024 SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer SpyBiotech
14-Aug-2024 Breakthrough heart MRI technique accurately predicts heart failure risk in general population The University of East Anglia (UEA)
14-Aug-2024 Cellomatics underpins continued US and European expansion with two business development hires Cellomatics Biosciences
14-Aug-2024 Santhera Closes Financings and Secures Funds to Reach Break-Even Expected in 2026 Santhera Pharmaceuticals
14-Aug-2024 New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease
14-Aug-2024 PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors PureTech Health plc
14-Aug-2024 NEJM publishes positive results for nipocalimab Phase 2 UNITY clinical study for early onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). Johnson & Johnson
14-Aug-2024 ViroCell Biologics completes oversubscribed financing ViroCell Biologics
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics
09-Aug-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024 Nxera Pharma